These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35780089)

  • 1. Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel.
    Petousis S; Hamilos M; Pagonidis K; Vardas P; Lazopoulos G; Anastasiou I; Zacharis E; Kochiadakis G; Skalidis E
    BMC Cardiovasc Disord; 2022 Jul; 22(1):301. PubMed ID: 35780089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
    Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.
    Berwanger O; Lopes RD; Moia DDF; Fonseca FA; Jiang L; Goodman SG; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Saraiva JFK; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Santos RHN; Paisani DM; Miranda TA; Valeis N; Piegas LS; Granger CB; White HD; Nicolau JC
    J Am Coll Cardiol; 2019 Jun; 73(22):2819-2828. PubMed ID: 30898608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infarct size following loading with Ticagrelor/Prasugrel versus Clopidogrel in ST-segment elevation myocardial infarction.
    Sabbah M; Nepper-Christensen L; Køber L; Høfsten DE; Ahtarovski KA; Göransson C; Kyhl K; Ghotbi AA; Schoos MM; Sadjadieh G; Kelbæk H; Lønborg J; Engstrøm T
    Int J Cardiol; 2020 Sep; 314():7-12. PubMed ID: 32389767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ticagrelor on Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction (HEALING-AMI).
    Park Y; Koh JS; Lee JH; Park JH; Shin ES; Oh JH; Chun W; Lee SY; Bae JW; Kim JS; Kim W; Suh JW; Yang DH; Hong YJ; Chan MY; Kang MG; Park HW; Hwang SJ; Hwang JY; Ahn JH; Choi SW; Jeong YH;
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2220-2234. PubMed ID: 33032710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Barbarawi M; Zayed Y; Hicks M; Ahmed S; Bachuwa G; Hassan M; Bhatt DL
    J Thromb Thrombolysis; 2018 Oct; 46(3):299-303. PubMed ID: 29934940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clopidogrel and ticagrelor under NT-proBNP in hospitalized ST-elevation acute coronary syndrome patients on percutaneous coronary intervention: CCC-ACS Project Analysis.
    Zhao X; Ai G; Qiu M; Wang X; Zhang L; Yang X; Liu Y; Xu P; Zhang J; Gu C; Zhou M; Hao Y; Zhao D; Han Y;
    Int J Cardiol; 2020 Jul; 310():1-8. PubMed ID: 32307186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
    Khan JN; Greenwood JP; Nazir SA; Lai FY; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman D; Peebles C; Wong J; Flather M; Swanton H; Gershlick AH; McCann GP
    J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27247336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial.
    Berwanger O; Nicolau JC; Carvalho AC; Jiang L; Goodman S; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Kerr Saraiva JF; Fonseca F; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Paisani DM; Lasagno CMR; Candido CT; Valeis N; Moia DDF; Piegas LS; Granger CB; White H; Lopes RD
    Am Heart J; 2018 Aug; 202():89-96. PubMed ID: 29908420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial.
    Hamilos M; Kanakakis J; Anastasiou I; Karvounis C; Vasilikos V; Goudevenos J; Michalis L; Koutouzis M; Tsiafoutis I; Raisakis K; Stakos D; Hahalis G; Vardas P;
    EuroIntervention; 2021 Feb; 16(14):1163-1169. PubMed ID: 32715996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
    Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
    BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
    Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
    J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction.
    Altıntaş B; Altındağ R; Bilge Ö; Baysal E; Öztürk Ö; Yaylak B; Ede H; Karahan MZ; Burak C; Tanboğa İH
    Int J Cardiol; 2019 Jul; 287():19-26. PubMed ID: 30979602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.
    Fonseca FAH; Izar MC; Maugeri IML; Berwanger O; Damiani LP; Pinto IM; Szarf G; França CN; Bianco HT; Moreira FT; Caixeta A; Alves CMR; Soriano Lopes A; Klassen A; Tavares MFM; Fonseca HA; Carvalho ACC;
    Trials; 2017 Dec; 18(1):601. PubMed ID: 29258572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-PCI corrected TIMI Frame Count predicts left ventricular global longitudinal strain at 90 days post-STEMI in thrombolysis-treated patients: A pre-specified analysis of the MIRTOS study.
    Anastasiou I; Patrianakos A; Vernardos M; Foukarakis E; Pitarokoilis M; Petousis S; Zacharis E; Marketou M; Skalidis E; Kochiadakis G; Parthenakis F; Vardas P; Hamilos M
    Am Heart J Plus; 2022 Nov; 23():100222. PubMed ID: 38560654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study.
    Berwanger O; Abdelhamid M; Alexander T; Alzubaidi A; Averkov O; Aylward P; Contreras Zúñiga E; Halvorsen S; Iglesias R; A Sk Abdul Kader M; Zubaid M; AlHabib KF
    Clin Cardiol; 2018 Oct; 41(10):1322-1327. PubMed ID: 30098028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Gill K; Servati N; Flahive J; Fraielli K
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):625-629. PubMed ID: 34236915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor Loading on ST-Elevation Myocardial Infarction: Interaction With Prodromal Angina on Infarct Size and Clinical Events.
    Faria JP; Oliveira P; Alexandre A; Couto DS; Costa R; Campinas A; Frias A; Brochado B; Santos R; Silveira J; Torres S; Luz A
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231169644. PubMed ID: 37194899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.